Table 8.
Group | Hepatocyte death | Inflammatory cell infiltration | Fibrosis | Combined score |
---|---|---|---|---|
Normal |
0.3 ± 0.2 |
3.0 ± 0.1 |
0.1 ± 0.1 |
0.3 ± 0.1 |
Model |
4.1 ± 0.7△△ |
3.3 ± 0.6△△ |
4.3 ± 0.7△△ |
4.0 ± 0.6△△ |
Sylimarin |
1.5 ± 0.7** |
1.6 ± 0.5** |
3.2 ± 0.5 |
2.6 ± 0.5* |
BBR |
1.3 ± 0.3** |
1.4 ± 0.5** |
1.8 ± 0.3** |
2.2 ± 0.5** |
CRAE |
1.5 ± 0.7** |
1.3 ± 0.6** |
2.2 ± 0.5** |
2.5 ± 0.4* |
BB |
1.6 ± 0.5** |
1.3 ± 30.5** |
1.2 ± 0.4** |
2.0 ± 0.4** |
TUDCA | 0.9 ± 0.4** | 0.7 ± 0.3** | 0.8 ± 0.3** | 1.0 ± 0.4** |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.